Alpha Tau Medical Ltd. Ordinary Shares (DRTS)
Alpha Tau Medical Ltd. is a biotechnology company specializing in innovative cancer treatment solutions. It developed the Alpha DaRT (Diffuse Dopant RadioTherapy), a novel radiation therapy that combines targeted radioactive sources with standard treatment protocols to enhance cancer cell destruction. The company focuses on advancing minimally invasive therapies with potential applications across various tumor types.
Company News
The global radiopharmaceuticals market is projected to grow at a CAGR of 10.3% from 2024 to 2030, driven by the increasing prevalence of chronic diseases, advancements in imaging technology, and the transition towards personalized medicine. North America and Asia-Pacific are the key regional markets.
TIMB, AKYA, DRTS, TRUP and QSG have been added to the Zacks Rank #1 (Strong Buy) List on January 8, 2024.
Alpha Tau Medical (NASDAQ:DRTS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for...
The stock enjoyed another big gain.